1000minds is used for prioritizing diseases for Research and Development.
Globally, there is an urgent need for new antibiotics to treat diseases that are becoming increasingly resistant to antibiotics. Millions of people are likely to die if new and effective antibiotics are not developed.
In 2016, Member States mandated the World Health Organization (WHO) to create a Priority Pathogens List (PPL) of antibiotic-resistant bacteria posing the greatest threats to human health. The main goal of the PPL is to guide R&D into new antibiotics by pharmaceutical companies, universities and public research institutions.
1000minds was used to survey and aggregate the preferences of experts in infectious diseases from around the world.
The European Centre for Disease Prevention and Control (ECDC) also used 1000minds to prioritize infectious disease threats.
About the use of 1000minds for prioritizing diseases for R&D.
- S Babashahi, P Hansen & T Sullivan (2021), “Creating a priority list of non-communicable diseases to support health research funding decision-making”, Health Policy 125, 221-28
- D Hunter, P Nicolson, C Little et al (2019), “Developing strategic priorities in osteoarthritis research: Proceedings and recommendations arising from the 2017 Australian Osteoarthritis Summit”, BMC Musculoskeletal Disorders 20, 74
- Y Mei, S Guan, H Zhang et al (2018), abstract, 2018 OARSI World Congress on Osteoarthritis, Liverpool, UK, 2018, “Priorities for osteoarthritis research in China”, Osteoarthritis & Cartilage 26(suppl 1), S220
- E Tacconelli, E Carrara, A Savoldi et al and the WHO Pathogens Priority List working group (2018), “Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis”, The Lancet Infectious Diseases 18, 318-27 News1 » News2 » News3 »
- P Hansen (2018), “The world’s deadliest diseases: The WHO priority list of antibiotic-resistant bacteria”, EcoNZ@Otago 40, 4-6
- Y Mei, S Guan, H Zhang, D Hunter, Z Zhang (2018), abstract, Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, The Netherlands, 2018, “Priorities for osteoarthritis research should be done in China”, Annals of the Rheumatic Diseases 77(suppl 2), 1613
- E Tacconelli, N Magrini & Co-ordinating Group, “Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics”, WHO Short Summary, 2017 News1 » News2 »
- European Centre for Disease Prevention and Control (2017), ECDC Tool for the Prioritization of Infectious Disease Threats – Handbook and Manual, ECDC
- K Weyer, E Tacconelli, N Magrini & Co-ordinating Group (2017), “Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis”, World Health Organization (WHO/EMP/IAU/2017.12) News3 »
- S French, P Beliveau, P Bruno et al (2017), “Research priorities of the Canadian chiropractic profession: a consensus study using a modified Delphi technique”, Chiropractic & Manual Therapies 25, 38